Filing Details

Accession Number:
0001213900-18-017210
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-11 16:21:19
Reporting Period:
2018-12-11
Accepted Time:
2018-12-11 16:21:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1553643 Relmada Therapeutics Inc. RLMD Pharmaceutical Preparations (2834) 455401931
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1658544 Edward Paul Kelly C/O Relmada Therapeutics, Inc.
750 Third Avenue, 9Th Floor
New York, NY 10016
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-11 5,000 $1.21 388,483 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct